Paper-based plasmonic platform for sensitive, noninvasive, and rapid cancer screening
Qian Liu1, Jiahong Wang2, Beike Wang1
1The State Key Laboratory Breeding Base of Basic Science of Stomatology (Hubei-MOST) & Key Laboratory of Oral Biomedicine Ministry of Education, Department of Periodontology, School & Hospital of Stomatology, Wuhan University, Wuhan, China.
Biosensors & Bioelectronics
|November 26, 2013
Summary
This study presents a novel, noninvasive cancer screening method using paper-based Surface-Enhanced Raman Scattering (SERS) with gold nanorods. The technology achieves 100% sensitivity and specificity for distinguishing cancerous cells.
Area of Science:
- Nanotechnology
- Biomedical Engineering
- Analytical Chemistry
Background:
- Surface-Enhanced Raman Scattering (SERS) offers potential for multiplexed molecular detection and cancer screening.
- Existing methods often lack sensitivity, invasiveness, or speed for early cancer detection.
Purpose of the Study:
- To develop a highly sensitive, noninvasive, and rapid cancer screening platform.
- To utilize exfoliative cytology combined with paper-based SERS technology for cancer diagnostics.
Main Methods:
- Fabrication of a SERS substrate using plasmonic gold nanorods (GNRs) adsorbed on filter paper.
- Acquisition of SERS spectra from exfoliated normal and cancerous cells.
- Development of a diagnostic algorithm based on spectral ratios (I1600/1440 and I1440/1340) to differentiate cell types.
Main Results:
- Distinct and reproducible SERS spectra were obtained from normal and cancerous cells, reflecting biomolecular changes.
- The diagnostic algorithm achieved 100% sensitivity and 100% specificity using specific peak ratios (I1600/1440 and I1440/1340).
- Performance metrics surpassed those obtained with the I1600/1340 ratio (70% sensitivity, 60% specificity).
Conclusions:
- The combination of exfoliative cytology and paper-based SERS provides a highly sensitive, rapid, and noninvasive approach for cancer screening.
- This technology demonstrates significant potential for clinical application in early cancer detection.
